Identification of tumor antigens with immunopeptidomics

0
4
Identification of tumor antigens with immunopeptidomics
Spread the love
  • 1.

    Kloetzel, P. M. Antigen processing by the proteasome. Nat. Rev. Mol. Cell Biol. 2, 179–187 (2001).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 2.

    Coulie, P. G. et al. A mutated intron sequence codes for an antigenic peptide known by cytolytic T lymphocytes on a human melanoma. Proc. Natl Acad. Sci. USA 92, 7976–7980 (1995).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 3.

    Roche, P. A. & Furuta, Okay. The fine details of MHC class II-mediated antigen processing and presentation. Nat. Rev. Immunol. 15, 203–216 (2015).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 4.

    Yewdell, J. W., Reits, E. & Neefjes, J. Making sense of mass destruction: quantitating MHC class I antigen presentation. Nat. Rev. Immunol. 3, 952–961 (2003).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 5.

    Schumacher, T. N., Scheper, W. & Kvistborg, P. Cancer neoantigens. Annu. Rev. Immunol. 37, 173–200 (2019).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 6.

    Bianchi, V., Harari, A. & Coukos, G. Neoantigen-deliver adoptive cell therapies for most cancers: making T-cell merchandise more personal. Entrance. Immunol. 11, 1215 (2020).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 7.

    Curran, M. A. & Glisson, B. S. Novel hope for therapeutic most cancers vaccines within the abilities of immune checkpoint modulation. Annu. Rev. Med. 70, 409–424 (2019).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 8.

    Haen, S. P., Löffler, M. W., Rammensee, H.-G. & Brossart, P. Towards novel horizons: characterization, classification and implications of the tumour antigenic repertoire. Nat. Rev. Clin. Oncol. 17, 595–610 (2020).

    PubMed 
    Article 
    PubMed Central 

    Google Pupil
     

  • 9.

    Kruger, S. et al. Advances in most cancers immunotherapy 2019: most trendy trends. J. Exp. Clin. Cancer Res. 38, 268 (2019).

    PubMed 
    PubMed Central 
    Article 

    Google Pupil
     

  • 10.

    Christofi, T., Baritaki, S., Falzone, L., Libra, M. & Zaravinos, A. Present views in most cancers immunotherapy. Cancers (Basel) 11, 1472 (2019).

    Article 
    CAS 

    Google Pupil
     

  • 11.

    Laumont, C. M. et al. Global proteogenomic analysis of human MHC class I-linked peptides derived from non-canonical reading frames. Nat. Commun. 7, 10238 (2016).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 12.

    Sebestyen, E. et al. Colossal-scale analysis of genome and transcriptome alterations in more than one tumors unveils novel most cancers-linked splicing networks. Genome Res. 26, 732–744 (2016).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 13.

    Zhao, Q. et al. Proteogenomics uncovers a huge repertoire of shared tumor-deliver antigens in ovarian most cancers. Cancer Immunol. Res. 8, 544–555 (2020).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 14.

    Ouspenskaia, T. et al. Hundreds of novel unannotated proteins develop the MHC I immunopeptidome in most cancers. Preprint at bioRxiv https://doi.org/10.1101/2020.02.12.945840 (2020).

  • 15.

    Chen, J. et al. Pervasive purposeful translation of noncanonical human originate reading frames. Science 367, 1140–1146 (2020).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 16.

    Ilyas, S. & Yang, J. C. Panorama of tumor antigens in T cell immunotherapy. J. Immunol. 195, 5117–5122 (2015).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 17.

    Caballero, O. L. & Chen, Y. T. Cancer/testis (CT) antigens: doable targets for immunotherapy. Cancer Sci. 100, 2014–2021 (2009).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 18.

    Tio, D. et al. Expression of most cancers/testis antigens in cutaneous melanoma: a systematic review. Melanoma Res. 29, 349–357 (2019).

    PubMed 
    Article 
    PubMed Central 

    Google Pupil
     

  • 19.

    Schooten, E., Di Maggio, A., van Bergen En Henegouwen, P. M. P. & Kijanka, M. M. MAGE-A antigens as targets for most cancers immunotherapy. Cancer Care for. Rev. 67, 54–62 (2018).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 20.

    D’Angelo, S. P. et al. Antitumor activity linked with extended persistence of adoptively transferred NY-ESO-1 c259T cells in synovial. Sarcoma 8, 944–957 (2018).


    Google Pupil
     

  • 21.

    Rapoport, A. P. et al. NY-ESO-1–deliver TCR–engineered T cells mediate sustained antigen-deliver antitumor results in myeloma. Nat. Med. 21, 914–921 (2015).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 22.

    Robbins, P. F. et al. A pilot trial the usage of lymphocytes genetically engineered with an NY-ESO-1–reactive T-cell receptor: lengthy-time length apply-up and correlates with response. Clin. Cancer Res. 21, 1019–1027 (2015).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 23.

    Laumont, C. M. & Perreault, C. Exploiting non-canonical translation to establish novel targets for T cell-primarily primarily based fully most cancers immunotherapy. Cell. Mol. Lifestyles Sci. 75, 607–621 (2018).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 24.

    Moreau-Aubry, A. et al. A processed pseudogene codes for a novel antigen known by a CD8+ T cell clone on melanoma. J. Exp. Med. 191, 1617–1623 (2000).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 25.

    Li, L.-J., Leng, R.-X., Fan, Y.-G., Pan, H.-F. & Ye, D.-Q. Translation of noncoding RNAs: focal point on lncRNAs, pri-miRNAs, and circRNAs. Exp. Cell Res. 361, 1–8 (2017).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 26.

    Charpentier, M. et al. IRES-dependent translation of the lengthy non coding RNA meloe in melanoma cells produces primarily the most immunogenic MELOE antigens. Oncotarget 7, 59704–59713 (2016).

    PubMed 
    PubMed Central 
    Article 

    Google Pupil
     

  • 27.

    Roulois, D. et al. DNA-demethylating agents arrangement colorectal most cancers cells by inducing viral mimicry by endogenous transcripts. Cell 162, 961–973 (2015).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 28.

    Chiappinelli, Okay. B. et al. Inhibiting DNA methylation causes an interferon response in most cancers by dsRNA including endogenous retroviruses. Cell 162, 974–986 (2015).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 29.

    Attermann, A. S., Bjerregaard, A. M., Saini, S. Okay., Gronbaek, Okay. & Hadrup, S. R. Human endogenous retroviruses and their implication for immunotherapeutics of most cancers. Ann. Oncol. 29, 2183–2191 (2018).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 30.

    Vigneron, N. et al. An antigenic peptide produced by peptide splicing within the proteasome. Science 304, 587–590 (2004).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 31.

    Delong, T. et al. Pathogenic CD4 T cells in form 1 diabetes acknowledge epitopes formed by peptide fusion. Science 351, 711–714 (2016).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 32.

    Yewdell, J. W. & Holly, J. DRiPs salvage molecular. Curr. Opin. Immunol. 64, 130–136 (2020).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 33.

    Welters, M. J. et al. Induction of tumor-deliver CD4+ and CD8+ T-cell immunity in cervical most cancers patients by a human papillomavirus form 16 E6 and E7 lengthy peptides vaccine. Clin. Cancer Res. 14, 178–187 (2008).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 34.

    Morgan, R. A. et al. Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene treatment. J. Immunother. 36, 133–151 (2013).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 35.

    Skipper, J. C. et al. Mass-spectrometric overview of HLA-A*0201-linked peptides identifies dominant naturally processed forms of CTL epitopes from MART-1 and gp100. Int J. Cancer 82, 669–677 (1999).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 36.

    Wolf, B. et al. Security and tolerability of adoptive cell treatment in most cancers. Drug Saf. 42, 315–334 (2019).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 37.

    Purcell, A. W., Ramarathinam, S. H. & Ternette, N. Mass spectrometry-primarily primarily based fully identification of MHC-plod peptides for immunopeptidomics. Nat. Protoc. 14, 1687–1707 (2019).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 38.

    Caron, E. et al. Prognosis of main histocompatibility complex (MHC) immunopeptidomes the usage of mass spectrometry. Mol. Cell. Proteom. 14, 3105–3117 (2015).

    Article 
    CAS 

    Google Pupil
     

  • 39.

    Ritz, D., Kinzi, J., Neri, D. & Fugmann, T. Data-self sustaining acquisition of HLA class I peptidomes on the Q exactive mass spectrometer platform. Proteomics 17, 1700177 (2017).

    Article 
    CAS 

    Google Pupil
     

  • 40.

    Gillet, L. C. et al. Centered recordsdata extraction of the MS/MS spectra generated by recordsdata-self sustaining acquisition: a novel thought for fixed and beautiful proteome analysis. Mol. Cell. Proteom. 11, O111.016717 (2012).

    Article 
    CAS 

    Google Pupil
     

  • 41.

    Brunner, A.-D. et al. Extremely-excessive sensitivity mass spectrometry quantifies single-cell proteome adjustments upon perturbation. Preprint at bioRxiv 2020.2012.2022.423933 (2020).

  • 42.

    Tsou, C. C. et al. DIA-Umpire: total computational framework for recordsdata-self sustaining acquisition proteomics. Nat. Suggestions 12, 258–264 (2015).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 43.

    Muntel, J. et al. Surpassing 10 000 identified and quantified proteins in a single speed by optimizing unique LC-MS instrumentation and recordsdata analysis device. Mol. Omics 15, 348–360 (2019).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 44.

    Gessulat, S. et al. Prosit: proteome-wide prediction of peptide tandem mass spectra by deep studying. Nat. Suggestions 16, 509–518 (2019).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 45.

    Croft, N. P. et al. Kinetics of antigen expression and epitope presentation during virus an infection. PLoS Pathog. 9, e1003129 (2013).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 46.

    Hassan, C. et al. Merely quantitation of MHC-plod peptides by utility of isotopically labeled peptide MHC complexes. J. Proteom. 109, 240–244 (2014).

    Article 
    CAS 

    Google Pupil
     

  • 47.

    Croft, N. P., Purcell, A. W. & Tscharke, D. C. Quantifying epitope presentation the usage of mass spectrometry. Mol. Immunol. 68, 77–80 (2015).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 48.

    Tan, C. T., Croft, N. P., Dudek, N. L., Williamson, N. A. & Purcell, A. W. Convey quantitation of MHC-plod peptide epitopes by chosen response monitoring. Proteomics 11, 2336–2340 (2011).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 49.

    Kapp, E. A. et al. An outline, comparison, and beautiful benchmarking of quite loads of publicly accessible MS/MS search algorithms: sensitivity and specificity analysis. Proteomics 5, 3475–3490 (2005).

  • 50.

    Kapp, E. & Schutz, F. Overview of tandem mass spectrometry (MS/MS) database search algorithms. Curr. Protoc. Protein Sci. 49, 25.2.1–25.2.19 (2007).

    Article 

    Google Pupil
     

  • 51.

    Elias, J. E. & Gygi, S. P. Target-decoy search device for increased self belief in effectively-organized-scale protein identifications by mass spectrometry. Nat. Suggestions 4, 207–214 (2007).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 52.

    Zhang, J. et al. PEAKS DB: de novo sequencing assisted database seek silent and beautiful peptide identification. Mol. Cell. Proteom. 11, M111.010587 (2012).

    Article 
    CAS 

    Google Pupil
     

  • 53.

    Shan, P. & Tran, H. Integrating database search and de novo sequencing for immunopeptidomics with DIA arrangement. J. Biomol. Tech. 30, S23 (2019).

    PubMed Central 

    Google Pupil
     

  • 54.

    Faridi, P., Purcell, A. W. & Croft, N. P. In immunopeptidomics we desire a sniper pretty than a shotgun. Proteomics 18, e1700464 (2018).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 55.

    Thompson, A. et al. Tandem mass tags: a novel quantification device for comparative analysis of complex protein mixtures by MS/MS. Anal. Chem. 75, 1895–1904 (2003).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 56.

    Pfammatter, S. et al. Extending the comprehensiveness of immunopeptidome analyses the usage of isobaric peptide labeling. Anal. Chem. 92, 9194–9204 (2020).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 57.

    Ramarathinam, S. H. et al. A peptide-signal amplification device for the detection and validation of neoepitope presentation on most cancers biopsies. Preprint at bioRxiv https://doi.org/10.1101/2020.06.12.145276 (2020).

  • 58.

    Stopfer, L. E., Mesfin, J. M., Joughin, B. A., Lauffenburger, D. A. & White, F. M. Multiplexed relative and absolute quantitative immunopeptidomics finds MHC I repertoire alterations prompted by CDK4/6 inhibition. Nat. Commun. 11, 2760 (2020).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 59.

    d’Atri, V. et al. Adding a novel separation dimension to MS and LC–MS: what’s the utility of ion mobility spectrometry? J. Sep. Sci. 41, 20–67 (2018).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 60.

    Pfammatter, S. et al. A novel differential ion mobility machine expands the depth of proteome coverage and the sensitivity of multiplex proteomic measurements. Mol. Cell. Proteom. 17, 2051–2067 (2018).

    Article 
    CAS 

    Google Pupil
     

  • 61.

    Pfammatter, S., Bonneil, E. & Thibault, P. Enchancment of quantitative measurements in multiplex proteomics the usage of excessive-field uneven waveform spectrometry. J. Proteome Res. 15, 4653–4665 (2016).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 62.

    Meier, F. et al. Online parallel accumulation-serial fragmentation (PASEF) with a novel trapped ion mobility mass spectrometer. Mol. Cell. Proteom. 17, 2534–2545 (2018).

    Article 
    CAS 

    Google Pupil
     

  • 63.

    Nesvizhskii, A. I. Proteogenomics: ideas, applications and computational suggestions. Nat. Suggestions 11, 1114–1125 (2014).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 64.

    Zhang, M. et al. RNA editing derived epitopes characteristic as most cancers antigens to elicit immune responses. Nat. Commun. 9, 3919 (2018).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 65.

    Wei, Z. et al. The panorama of tumor fusion neoantigens: a pan-most cancers. Anal. iScience 21, 249–260 (2019).

    Article 

    Google Pupil
     

  • 66.

    Löffler, M. W. et al. Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma. Genome Med. 11, 28 (2019).

    PubMed 
    PubMed Central 
    Article 

    Google Pupil
     

  • 67.

    Kalaora, S. et al. Exercise of HLA peptidomics and total exome sequencing to establish human immunogenic neo-antigens. Oncotarget 7, 5110–5117 (2016).

    PubMed 
    PubMed Central 
    Article 

    Google Pupil
     

  • 68.

    Bassani-Sternberg, M., Pletscher-Frankild, S., Jensen, L. J. & Mann, M. Mass spectrometry of human leukocyte antigen class I peptidomes finds stable results of protein abundance and turnover on antigen presentation. Mol. Cell. Proteom. 14, 658–673 (2015).

    Article 
    CAS 

    Google Pupil
     

  • 69.

    Khodadoust, M. S. et al. Antigen presentation profiling finds recognition of lymphoma immunoglobulin neoantigens. Nature 543, 723–727 (2017).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 70.

    Bassani-Sternberg, M. et al. Convey identification of clinically linked neoepitopes presented on native human melanoma tissue by mass spectrometry. Nat. Commun. 7, 13404 (2016).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 71.

    Binz, P. A. et al. Proteomics Standards Initiative extended FASTA structure. J. Proteome Res. 18, 2686–2692 (2019).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 72.

    Eng, J. Okay. & Deutsch, E. W. Extending comet for global amino acid variant and put up-translational modification analysis the usage of the PSI extended FASTA structure. Proteomics 72, e1900362 (2020).

    Article 
    CAS 

    Google Pupil
     

  • 73.

    Elias, J. E. & Gygi, S. P. Target-decoy search device for mass spectrometry-primarily primarily based fully proteomics. Suggestions Mol. Biol. 604, 55–71 (2010).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 74.

    Gupta, N., Bandeira, N., Keich, U. & Pevzner, P. A. Target-decoy arrangement and spurious discovery price: when issues will also bound fallacious. J. Am. Soc. Mass Spectrom. 22, 1111–1120 (2011).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 75.

    Tanner, S. et al. Making improvements to gene annotation the usage of peptide mass spectrometry. Genome Res. 17, 231–239 (2007).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 76.

    Chong, C. et al. Constructed-in proteogenomic deep sequencing and analytics accurately establish non-canonical peptides in tumor immunopeptidomes. Nat. Commun. 11, 1293 (2020).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 77.

    Laumont, C. M. et al. Noncoding regions are the principle source of targetable tumor-deliver antigens. Sci. Transl. Med. 10, eaau5516 (2018).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 78.

    Natty, A. C. et al. Intron retention is a source of neoepitopes in most cancers. Nat. Biotechnol. 36, 1056–1058 (2018).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 79.

    Attig, J. et al. LTR retroelement expansion of the human most cancers transcriptome and immunopeptidome published by de novo transcript meeting. Genome Res. 29, 1578–1590 (2019).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 80.

    Kong, Y. et al. Transposable component expression in tumors is expounded with immune infiltration and increased antigenicity. Nat. Commun. 10, 5228 (2019).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 81.

    Shraibman, B., Melamed Kadosh, D., Barnea, E. & Admon, A. HLA peptides derived from tumor antigens prompted by inhibition of DNA methylation for declare of drug-facilitated immunotherapy. Mol. Cell. Proteom. 15, 3058–3070 (2016).

    Article 
    CAS 

    Google Pupil
     

  • 82.

    Calviello, L. et al. Detecting actively translated originate reading frames in ribosome profiling recordsdata. Nat. Suggestions 13, 165–170 (2016).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 83.

    Erhard, F. et al. Improved Ribo-seq enables identification of cryptic translation occasions. Nat. Suggestions 15, 363–366 (2018).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 84.

    Ingolia, N. T. et al. Ribosome profiling finds pervasive translation outdoors of annotated protein-coding genes. Cell Accumulate. 8, 1365–1379 (2014).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 85.

    Slavoff, S. A. et al. Peptidomic discovery of short originate reading physique–encoded peptides in human cells. Nat. Chem. Biol. 9, 59–64 (2013).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 86.

    Sarkizova, S. et al. A effectively-organized peptidome dataset improves HLA class I epitope prediction across many of the human population. Nat. Biotechnol. 38, 199–209 (2020).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 87.

    Abelin, J. G. et al. Mass spectrometry profiling of HLA-linked peptidomes in mono-allelic cells enables more beautiful epitope prediction. Immunity 46, 315–326 (2017).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 88.

    Warren, E. H. et al. An antigen produced by splicing of noncontiguous peptides within the reverse hiss. Science 313, 1444–1447 (2006).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 89.

    Dalet, A. et al. An antigenic peptide produced by reverse splicing and double asparagine deamidation. Proc. Natl Acad. Sci. USA 108, E323–E331 (2011).

    PubMed 
    PubMed Central 
    Article 

    Google Pupil
     

  • 90.

    Michaux, A. et al. A spliced antigenic peptide comprising a single spliced amino acid is produced within the proteasome by reverse splicing of a longer peptide fragment followed by trimming. J. Immunol. 192, 1962–1971 (2014).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 91.

    Hanada, Okay., Yewdell, J. W. & Yang, J. C. Immune recognition of a human renal most cancers antigen thru put up-translational protein splicing. Nature 427, 252–256 (2004).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 92.

    Liepe, J. et al. A effectively-organized allotment of HLA class I ligands are proteasome-generated spliced peptides. Science 354, 354–358 (2016).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 93.

    Faridi, P. et al. A subset of HLA-I peptides are no longer genomically templated: proof for cis- and trans-spliced peptide ligands. Sci. Immunol. 3, eaar3947 (2018).

    PubMed 
    Article 
    PubMed Central 

    Google Pupil
     

  • 94.

    Liepe, J., Sidney, J., Lorenz, F. Okay. M., Sette, A. & Mishto, M. Mapping the MHC class I–spliced immunopeptidome of most cancers cells. Cancer Immunol. Res. 7, 62–76 (2019).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 95.

    Paes, W. et al. Contribution of proteasome-catalyzed peptide cis-splicing to viral focusing on by CD8+ T cells in HIV-1 an infection. Proc. Natl Acad. Sci. USA 116, 24748–24759 (2019).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 96.

    Faridi, P. et al. Spliced peptides and cytokine-driven adjustments within the immunopeptidome of melanoma. Cancer Immunol. Res. 8, 1322–1334 (2020).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 97.

    Mylonas, R. et al. Estimating the contribution of proteasomal spliced peptides to the HLA-I ligandome. Mol. Cell. Proteom. 17, 2347–2357 (2018).

    Article 
    CAS 

    Google Pupil
     

  • 98.

    Rolfs, Z., Solntsev, S. Okay., Shortreed, M. R., Frey, B. L. & Smith, L. M. Global identification of put up-translationally spliced peptides with neo-fusion. J. Proteome Res. 18, 349–358 (2019).

    PubMed 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 99.

    Erhard, F., Dölken, L., Schilling, B. & Schlosser, A. Identification of the cryptic HLA-I immunopeptidome. Cancer Immunol. Res. 8, 1018–1026 (2020).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 100.

    Vigneron, N., Ferrari, V., Stroobant, V., Abi Habib, J. & Van den Eynde, B. J. Peptide splicing by the proteasome. J. Biol. Chem. 292, 21170–21179 (2017).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 101.

    Dalet, A., Vigneron, N., Stroobant, V., Hanada, Okay. & Van den Eynde, B. J. Splicing of distant peptide fragments happens within the proteasome by transpeptidation and produces the spliced antigenic peptide derived from fibroblast declare ingredient-5. J. Immunol. 184, 3016–3024 (2010).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 102.

    Henry, V. J., Bandrowski, A. E., Pepin, A. S., Gonzalez, B. J. & Desfeux, A. OMICtools: an informative directory for multi-omic recordsdata analysis. Database (Oxford) 2014, bau069 (2014).

    Article 
    CAS 

    Google Pupil
     

  • 103.

    Afgan, E. et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update. Nucleic Acids Res. 46, W537–W544 (2018).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 104.

    Nesvizhskii, A. I. et al. Dynamic spectrum quality overview and iterative computational analysis of shotgun proteomic recordsdata: in opposition to more environment friendly identification of put up-translational adjustments, sequence polymorphisms, and novel peptides. Mol. Cell. Proteom. 5, 652–670 (2006).

    Article 
    CAS 

    Google Pupil
     

  • 105.

    Andreatta, M. et al. MS-Rescue: a computational pipeline to amplify the quality and yield of immunopeptidomics experiments. Proteomics 19, e1800357 (2019).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 106.

    Rolfs, Z., Müller, M., Shortreed, M. R., Smith, L. M. & Bassani-Sternberg, M. Touch upon ‘A subset of HLA-I peptides are no longer genomically templated: proof for cis- and trans-spliced peptide ligands’. Sci. Immunol. 4, eaaw1622 (2019).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 107.

    McGranahan, N. & Swanton, C. Clonal heterogeneity and tumor evolution: previous, unique, and the lengthy speed. Cell 168, 613–628 (2017).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 108.

    Marcu, A. et al. The HLA Ligand Atlas. A resource of pure HLA ligands presented on benign tissues. J. Immunother. Cancer 9, e002071 (2019).

    Article 

    Google Pupil
     

  • 109.

    Schatton, T. et al. Identification of cells initiating human melanomas. Nature 451, 345–349 (2008).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 110.

    Lang, D., Mascarenhas, J. B. & Shea, C. R. Melanocytes, melanocyte stem cells, and melanoma stem cells. Clin. Dermatol. 31, 166–178 (2013).

    PubMed 
    PubMed Central 
    Article 

    Google Pupil
     

  • 111.

    Kassiotis, G. & Stoye, J. P. Immune responses to endogenous retroelements: taking the unsuitable with the correct. Nat. Rev. Immunol. 16, 207–219 (2016).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 112.

    Rycaj, Okay. et al. Cytotoxicity of human endogenous retrovirus Okay–deliver T cells in opposition to autologous ovarian. Cancer Cells 21, 471–483 (2015).

    CAS 

    Google Pupil
     

  • 113.

    Saini, S. Okay. et al. Human endogenous retroviruses salvage a reservoir of T cell targets in hematological cancers. Nat. Commun. 11, 5660 (2020).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 114.

    Mullins, C. S. & Linnebacher, M. Endogenous retrovirus sequences as a novel class of tumor-deliver antigens: an instance of HERV-H env encoding stable CTL epitopes. Cancer Immunol. Immun. 61, 1093–1100 (2012).

    Article 
    CAS 

    Google Pupil
     

  • 115.

    Tu, X. et al. Human leukemia antigen-A*0201-restricted epitopes of human endogenous retrovirus W household envelope (HERV-W env) induce stable cytotoxic T lymphocyte responses. Virol. Sin. 32, 280–289 (2017).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 116.

    Belgnaoui, S. M., Gosden, R. G., Semmes, O. J. & Haoudi, A. Human LINE-1 retrotransposon induces DNA injure and apoptosis in most cancers cells. Cancer Cell Int. 6, 13 (2006).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 117.

    Scott, E. C. et al. A sizzling L1 retrotransposon evades somatic repression and initiates human colorectal most cancers. Genome Res. 26, 745–755 (2016).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 118.

    Ott, P. A. et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature 547, 217–221 (2017).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 119.

    Sahin, U. et al. Personalized RNA mutanome vaccines mobilize poly-deliver therapeutic immunity in opposition to most cancers. Nature 547, 222–226 (2017).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 120.

    Ebrahimi-Nik, H. et al. Mass spectrometry driven exploration finds nuances of neoepitope-driven tumor rejection. JCI Perception 5, e129152 (2019).

    Article 

    Google Pupil
     

  • 121.

    Smith, C. C. et al. Different tumour-deliver antigens. Nat. Rev. Cancer 19, 465–478 (2019).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 122.

    Jackson, R. et al. The interpretation of non-canonical originate reading frames controls mucosal immunity. Nature 564, 434–438 (2018).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 123.

    Muller, M., Gfeller, D., Coukos, G. & Bassani-Sternberg, M. ‘Hotspots’ of antigen presentation published by human leukocyte antigen ligandomics for neoantigen prioritization. Entrance. Immunol. 8, 1367 (2017).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 124.

    Schittenhelm, R. B. et al. A total analysis of constitutive naturally processed and presented HLA-C*04: 01 (Cw4)-deliver peptides. Tissue Antigen. 83, 174–179 (2014).

    Article 
    CAS 

    Google Pupil
     

  • 125.

    Schuster, H. et al. The immunopeptidomic panorama of ovarian carcinomas. Proc. Natl Acad. Sci. USA 114, E9942–E9951 (2017).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • 126.

    Sarkizova, S. et al. A effectively-organized peptidome dataset improves HLA class I epitope prediction across many of the human population. Nat. Biotechnol. 38, 199–209 (2020).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 127.

    Keskin, D. B. et al. Neoantigen vaccine generates intratumoral T cell responses in Share Ib glioblastoma trial. Nature 565, 234–239 (2019).

    PubMed 
    Article 
    CAS 
    PubMed Central 

    Google Pupil
     

  • 128.

    Shraibman, B. et al. Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma. Mol. Cell. Proteom. 17, 2132–2145 (2018).

    Article 
    CAS 

    Google Pupil
     

  • 129.

    Ternette, N. et al. Immunopeptidomic profiling of HLA-A2-certain triple harmful breast most cancers identifies doable immunotherapy arrangement antigens. Proteomics 18, 1700465 (2018).

    PubMed Central 
    Article 
    CAS 

    Google Pupil
     

  • Be taught Extra

    Leave a reply